October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced quantification capabilities in a solution that integrates quantitative analysis software for cardiology and radiology with ProSolv’s industry-leading cardiovascular image and information system (CVIIS).
These capabilities are a result of ProSolv’s corporate partnership with Pie Medical Imaging BV (PMI, Maastricht, the Netherlands), a developer of. PMI’s CAAS 5 software can be launched directly from the ProSolv application. This enables QCA and LVA assessment including quantitative measurements of the dimensions of coronary arteries and analysis of the left ventricle immediately and without the added step of accessing a separate program. Furthermore, ProSolv has closed the loop by exporting the findings of the analysis – the analyzed images, reports, discrete data and any other pertinent details – directly into the ProSolv database and clinical report.
“Providing healthcare facilities with improved workflow, consistency, and accuracy in reporting from the both the clinical and administrative sides are paramount to us and our ongoing product development. The integration of PMI’s CAAS application within the ProSolv application enables us to address their unique workflow needs, allowing us to continue to deliver solutions that bring additional value to our customers,” said ProSolv President and CEO, Aaron Waitz.
“The ProSolv – PMI alliance presents a unique opportunity for the two companies to create a comprehensive, state-of-the-art solution for healthcare facilities and physician practices,” stated PMI’s CEO Boudewijn Verstraelen. “We look forward to continuing a productive relationship with ProSolv.”
For more information: www.prosolv.com
June 27, 2022 
